[144] Keurig Dr Pepper Inc. SEC Filing

Rhea-AI Filing Summary

Keurig Dr Pepper Inc. (KDP) Form 144 notice reports a proposed sale of 7,601 common shares through Morgan Stanley Smith Barney with an aggregate market value of $267,403.18, targeted for 08/20/2025 on NASDAQ. The shares were acquired as restricted stock units on 03/04/2024. The filing also discloses three prior 10b5-1 sales by the Robert J. Gamgort 1999 Trust of 208,000 shares each on 06/02/2025, 07/29/2025, and 08/01/2025, generating gross proceeds of approximately $6.89M, $6.90M, and $6.84M respectively.

The notice includes the standard representation that the seller does not possess undisclosed material adverse information and references reliance on Rule 10b5-1 where applicable. No financial results, corporate operational details, or forward-looking statements are included in this filing.

Positive

• Use of Rule 10b5-1 plans for the three large trust sales indicates pre-planned, systematic dispositions rather than opportunistic trades
• Timely and detailed disclosure of broker, share counts, acquisition type (RSUs), and sale dates supports regulatory compliance and investor transparency

Negative

• Substantial insider-related selling: three 10b5-1 sales totaled 624,000 shares for approximately $20.6M in gross proceeds over three months, which could be viewed negatively by some investors
• Filer-level identity and certain issuer details are not fully specified in the provided extract (CIK/issuer name fields are blank), limiting contextual assessment

Insights

Securities Analyst

TL;DR: Routine insider sale under Rule 10b5-1 with meaningful recent dispositions by a trust; not an operational disclosure.

The filing documents a small planned sale of 7,601 RSU-derived shares for ~$267k and highlights three large 10b5-1 sales by the Robert J. Gamgort trust totaling 624,000 shares and roughly $20.6M gross proceeds over three months. For investors, this is a disclosure of insider liquidity rather than a signal about company fundamentals because the transactions appear to be executed under pre-established plans. The filing contains no earnings, balance sheet, or strategic information that would change valuation models.

Corporate Governance Expert

TL;DR: Proper Rule 144/10b5-1 mechanics observed; disclosure is compliance-focused, not a governance event.

The record shows the seller represented absence of undisclosed material information and identified use of a broker and 10b5-1 sales by a related trust. From a governance perspective, timely filing and explicit use of a broker and plan dates are best-practice compliance actions. The filing does not disclose any departures, related-party transactions beyond the trust sales, or governance concerns.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7601	267403.18	1358435279	08/20/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/04/2024	Restricted Stock Units	Issuer			7601	03/04/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ROBERT J. GAMGORT 1999 TRUST U/A DTD 12/17/1999 53 South Avenue Burlington MA 01803	Common	08/01/2025	208000	6842804.80
10b5-1 Sales for ROBERT J. GAMGORT 1999 TRUST U/A DTD 12/17/1999 53 South Avenue Burlington MA 01803	Common	07/29/2025	208000	6901918.40
10b5-1 Sales for ROBERT J. GAMGORT 1999 TRUST U/A DTD 12/17/1999 53 South Avenue Burlington MA 01803	Common	06/02/2025	208000	6885486.40

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares did KDP report for proposed sale on Form 144?

The filing reports a proposed sale of 7,601 common shares (RSU origin) with aggregate market value of $267,403.18 scheduled for 08/20/2025 on NASDAQ.

Were there recent insider sales related to KDP disclosed in the filing?

Yes. The Robert J. Gamgort 1999 Trust reported three 10b5-1 sales of 208,000 shares each on 06/02/2025, 07/29/2025, and 08/01/2025, generating gross proceeds of about $6.89M, $6.90M, and $6.84M respectively.

How were the 7,601 shares originally acquired?

They were acquired as Restricted Stock Units (RSUs) on 03/04/2024 from the issuer.

Does this Form 144 indicate undisclosed material information about KDP?

No. The filer represented they do not know any undisclosed material adverse information; the filing itself contains no operational or financial disclosures.

Which broker is handling the proposed sale?

The proposed sale is through Morgan Stanley Smith Barney LLC, Executive Financial Services, New York, NY.